Sotera Health CompanySHCNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -6.46% | +2.56% | +6.42% | +9.05% | +4.56% |
| Gross Profit Growth | -8.73% | +6.54% | +9.05% | +12.36% | +0.95% |
| EBITDA Growth | -15.30% | -28.28% | -0.15% | +8.65% | +15.93% |
| Operating Income Growth | -16.23% | +7.28% | +15.14% | +38.10% | +56.20% |
| Net Income Growth | -68.14% | -309.71% | -9.05% | +184.74% | +182.78% |
| EPS Growth | -69.07% | -309.87% | -9.39% | +183.33% | +177.14% |
| EPS Diluted Growth | -68.93% | -310.81% | -9.12% | +185.71% | +175.86% |
| Weighted Average Shares Growth | +0.52% | +0.58% | +0.37% | +0.36% | +0.41% |
| Weighted Average Shares Diluted Growth | +0.55% | -0.18% | +0.43% | +0.41% | +0.53% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -50.75% | +472.44% | -6.33% | -27.24% | +84.23% |
| Free Cash Flow Growth | -121.02% | +0.00% | +35.17% | -43.61% | +0.00% |
| Receivables Growth | -5.53% | +8.27% | +11.97% | +10.51% | +6.31% |
| Inventory Growth | +1.74% | +18.90% | +3.59% | +2.47% | +10.61% |
| Asset Growth | -1.88% | +1.24% | +5.20% | +1.19% | +6.24% |
| Book Value per Share Growth | -9.22% | -4.12% | +20.50% | +16.67% | +49.05% |
| Debt Growth | +1.01% | +0.01% | +0.11% | -3.40% | -3.27% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +2.45% | +8.34% | +13.73% | +2.07% | -6.99% |